Substantial evidence has revealed that GSK3β, which functions as a major Tau kinase and a downstream target of the PI3K/AKT signaling pathway, regulates both Tau phosphorylation and Aβ production in AD (Qi et al., 2017). Here, MAPT is linked to Alzheimer disease.